Bio-Path Holdings, Inc. 8-K Filing: Key Insights from January 10, 2025 Report

Based on the provided section of the financial report, here are the key insights and information extracted:

Entity Details:

Company Name: Bio-Path Holdings, Inc.
CIK Identifier: 0001133818
State of Incorporation: Delaware (DE)
SEC File Number: 001-36333
Employer Identification Number (EIN): 87-0652870

Address:

4710 Bellaire Boulevard, Suite 210, Bellaire, TX 77401
Contact Number: 832-742-1357

Filing Information:

Form Type: 8-K
Filing Date: January 10, 2025

Security Information:

Security Type: Common Stock
Par Value: $0.001 per share
Ticker Symbol: BPTH
Exchange: NASDAQ

Reporting Period:

Start Date: January 10, 2025
End Date: January 10, 2025

Summary of Insights:

The report indicates an 8-K filing by Bio-Path Holdings, Inc., which typically reveals significant events or changes that might be important to investors.
The company operates in the biotechnology sector, as inferred from its name.
The common stock is listed on NASDAQ, suggesting it is a publicly traded company, indicating transparency and regulatory compliance.
The date of the report corresponds precisely with the reporting period, which could signify a specific event or disclosure that occurred on that date.

This snapshot provides a foundation for further analysis on the company's performance, events reported on the 8-K, and overall market sentiment towards Bio-Path Holdings, Inc.